Miami, FL – July 28, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Glucose Health, Inc. (OTC Pink: GLUC).
Keith Speights, a Motley Fool Contributor just last week spotlighted the “3 Top Pharma Stocks to Buy Right Now
- AstraZeneca (NYSE: AZN) best known for its cancer drug Tagrisso, which generated year over year growth of 56%.
- Bristol Myers Squibb (NYSE: BMY) is a name everybody knows, whose growth could be even better than AZN’s. The Celgene acquisition highlighted more blockbuster cancer drugs such as Revlimid, Pomalyst, and Abraxane.
- Eli Lilly (NYSE: LLY) continues to dominate several categories highlighting its diabetes products Trulicity, Basaglar, and Jardiance and analysts are expecting annual sales growth to come in around 13.5% over the next 5 years.
All three of these companies are up about an average of 25% over the past 12 months.
Glucose Health, Inc. (OTC Pink: GLUC) just reported triple-digit sales increases of its innovative diabetic nutrition beverage GLUCODOWN® at Amazon during the onset of COVID-19. GLUCODOWN® is also sold nationwide in-store at Walmart pharmacies (NYSE: WMT), now the third largest pharmacy retailer after Walgreens and CVS.
With only 12.5 million shares outstanding, GLUC could be the single best value in the diabetes space and should be on everybody’s watch list. Right now, Glucose Health, Inc. (OTC Pink: GLUC), is trading at $1.39, below its all-time high of $1.99 per share.
What are revenues for this growth company going to look like when the latest sales during the pandemic hit GLUC’s financial statements in Q2 and Q3?
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.